Noventure, as part of its ongoing activities in support of the launch of Gelsectan®, participated with a stand at the IBS Days 2018 in Bologne, Italy, May 17 - 19, 2018. This meeting is intended to provide current views and a look to the future on the rapidly advancing field of IBS. One of the lectures was devoted to mucosal barrier and permeability, which is a hot topic among gastroenterologists specialized in IBS management. Gelsectan® contains mucoprotectors which improve the resistance of the mucosal barrier and help restore its normal function. It is intended to relieve and prevent IBS symptoms such as chronic or relapsing diarrhoea, pain and bloating.